ACCRUED LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2022

Payables and Accruals [Abstract]

Schedule of accrued expenses

Accrued liabilities at December 31, 2022 and 2021 consisted of the following:

	December 31,
(In thousands)	2022		2021
Compensation	$	201,252	$	183,517
Pfizer, Inc. (“Pfizer”) Promotion Agreement related costs	—		91,436
Professional fees	43,715		50,077
Other	22,329		32,116
Assets under construction	10,462		22,611
Research and trial related expenses	17,455		15,534
Licenses	4,003		3,265
Total	$	299,216	$	398,556